Neuberger Berman Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-173,122	Closed	-$20M	–	1953
2023 Q3	$20M	Sell	173,122 -95,215	-35%	-$10.2M	0.02%	599
2023 Q2	$27.6M	Sell	268,337 -62,987	-19%	-$6.65M	0.02%	542
2023 Q1	$36.2M	Sell	331,324 -368,842	-53%	-$40.8M	0.03%	491
2022 Q4	$79.7M	Sell	700,166 -818,874	-54%	-$68M	0.08%	305
2022 Q3	$94M	Buy	1,519,040 +1,038,577	+216%	+$72.6M	0.1%	272
2022 Q2	$38.3M	Buy	480,463 +106,156	+28%	+$10.1M	0.04%	485
2022 Q1	$39.4M	Buy	374,307 +29,377	+9%	+$2.86M	0.03%	524
2021 Q4	$37.1M	Sell	344,930 -92,389	-21%	-$10.1M	0.03%	551
2021 Q3	$47.8M	Buy	437,319 +101	+0%	+$10.5K	0.04%	473
2021 Q2	$40.9M	Buy	437,218 +6,034	+1%	+$555K	0.04%	517
2021 Q1	$39.6M	Sell	431,184 -17,799	-4%	-$1.5M	0.04%	508
2020 Q4	$32.8M	Buy	448,983 +101,930	+29%	+$7.58M	0.03%	520
2020 Q3	$27M	Buy	347,053 +89,303	+35%	+$6.14M	0.03%	505
2020 Q2	$14.3M	Buy	257,750 +177,750	+222%	+$7.6M	0.02%	648
2020 Q1	$2.37M	Buy	80,000 +7,100	+10%	+$240K	﹤0.01%	910
2019 Q4	$2.64M	Hold	72,900	–	–	﹤0.01%	969
2019 Q3	$1.99M	Buy	+72,900	New	+$1.88M	﹤0.01%	1012
2018 Q3	–	Sell	-20,000	Closed	-$331K	–	1742
2018 Q2	$331K	Buy	+20,000	New	+$305K	﹤0.01%	1481
2017 Q3	–	Sell	-602,070	Closed	-$7.15M	–	1668
2017 Q2	$7.15M	Buy	+602,070	New	+$7.49M	0.01%	805
2014 Q4	–	Sell	-11,785	Closed	-$144K	–	1723
2014 Q3	$144K	Sell	11,785 -840,050	-99%	-$9.76M	﹤0.01%	1603
2014 Q2	$13.5M	Buy	851,835 +250,085	+42%	+$3.57M	0.01%	763
2014 Q1	$9.1M	Buy	+601,750	New	+$6.8M	0.01%	820

Other funds holding HZNP